Verrica Pharmaceuticals buy Needham & Company LLC
Start price
23.08.23
/
50%
€3.90
Target price
23.08.24
€9.25
Performance (%)
74.36%
Price
07.05.24
€6.69
Summary
This prediction is currently active. With a performance of 74.36% the BUY prediction by Needham___Company_LL is a big success. This prediction currently runs until 23.08.24. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Verrica Pharmaceuticals | 4.493% | 4.493% |
iShares Core DAX® | 2.831% | 1.236% |
iShares Nasdaq 100 | 2.918% | 0.640% |
iShares Nikkei 225® | 2.007% | -2.135% |
iShares S&P 500 | 2.257% | 0.451% |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $10.00 price target on the stock.
Ratings data for VRCA provided by MarketBeat
Stopped prediction by Needham___Company_LL for Verrica Pharmaceuticals
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€2.74
10.11.23
10.11.23
€7.49
10.11.24
10.11.24
143.80%
07.05.24
07.05.24